Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

GILEAD SCIENCES, INC.

(GILD)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about GILEAD SCIENCES, INC.
01/25Gilead Announces Partial Clinical Hold for Studies Evaluating Magrolimab in Combination..
BU
01/24Gilead Sciences-FDA Approves Veklury (Remdesivir) for the Treatment of Non-Hospitalized..
AQ
01/24Gilead Secures FDA Approval for Veklury in Non-Hospitalized COVID-19 Patients at High R..
MT
01/21Gilead Gets FDA Approval for Remdesivir for Some Non-Hospitalized Patients
DJ
01/21FDA Approves Veklury« (Remdesivir) for the Treatment of Non-Hospitalized Patients at Hi..
BU
01/21Gilead Sciences, Inc. Announces FDA Approves Veklury« for the Treatment of Non-Hospital..
CI
01/19GILEAD SCIENCES : Announces Actions to Remove Counterfeit HIV Medications from U.S. Supply..
PU
01/18Gilead says counterfeit HIV drugs ended up with patients
RE
01/18Gilead Sciences to Release Fourth Quarter & Full Year 2021 Financial Results on Tuesday..
BU
01/18Morgan Stanley Lowers Price Target for Gilead Sciences to $72 From $74, Maintains Equal..
MT
01/18Gilead says counterfeiting network sold $250 mln worth of its HIV drugs
RE
01/14Gilead withdraws use of Zydelig to treat two types of cancer
RE
01/14Gilead withdraws use of Zydelig to treat two types of cancer
RE
01/14GILEAD SCIENCES : Statement on Zydelig« U.S. Indication for Follicular Lymphoma and Small ..
PU
01/11Gilead Announces Clinical Trial Collaborations With Merck to Evaluate Trodelvy in Combi..
AQ
More most relevant news
All news about GILEAD SCIENCES, INC.
01/25Gilead Announces Partial Clinical Hold for Studies Evaluating Magrolimab in Combination..
BU
01/25Sierra Oncology's bone marrow cancer drug meets study main goal
RE
01/24U.S. FDA limits use of Regeneron, Lilly COVID-19 antibody treatments
RE
01/24Gilead Sciences-FDA Approves Veklury (Remdesivir) for the Treatment of Non-Hospitalized..
AQ
01/24Gilead Secures FDA Approval for Veklury in Non-Hospitalized COVID-19 Patients at High R..
MT
01/21Gilead Gets FDA Approval for Remdesivir for Some Non-Hospitalized Patients
DJ
01/21FDA Approves Veklury« (Remdesivir) for the Treatment of Non-Hospitalized Patients at Hi..
BU
01/21Gilead Sciences, Inc. Announces FDA Approves Veklury« for the Treatment of Non-Hospital..
CI
01/19GLOBAL MARKETS LIVE : Bank of America, ASML, Intel, Oracle, Burberry...
01/19WALL STREET STOCK EXCHANGE : Temporary respite for the Nasdaq
More news
News in other languages on GILEAD SCIENCES, INC.
01/25USA : Fda: Regeneron ed Eli Lilly, inefficaci contro Omicron
01/21Gilead Sciences, Inc. annonce que la FDA approuve Veklury« (Remdesivir) pour le traitem..
01/21BB Biotech schreibt im 2021 hohen Verlust
01/21OMIKRON UND CORONA-MEDIKAMENTE : Was hilft gegen die neue Variante?
01/21BB Biotech boucle l'année 2021 sur une perte
01/20Paxlovid von Pfizer erste Behandlungsoption bei bestimmten Covid-Patienten
01/19PLANÈTE BOURSE : La revue de presse du mercredi 19 janvier 2022
01/19USA-Les valeurs à suivre à Wall Street (actualisé)
01/13La société britannique Countryside Properties dégringole suite au départ de son PDG et ..
01/13Countryside dégringole de 17% après la démission de son PDG suite à un accord avec un i..
More news
Analyst Recommendations on GILEAD SCIENCES, INC.
01/19ANALYST RECOMMENDATIONS : Activision Blizzard, Chevron, Exxon Mobil, Gilead, Goldman Sachs..
01/18Morgan Stanley Lowers Price Target for Gilead Sciences to $72 From $74, Maintains Equal..
MT
01/06Morgan Stanley Downgrades Gilead Sciences to Equalweight From Overweight, Cuts Price Ta..
MT
01/06RBC Lifts Price Target on Gilead Sciences to $87 From $86, Maintains Outperform Rating
MT
01/06ANALYST RECOMMENDATIONS : Bank of America, Dollar General, Evercore, Reckitt Benckiser, Un..
More recommendations
Press releases
01/25Gilead Announces Partial Clinical Hold for Studies Evaluating Magrolimab in Combination..
BU
01/24Gilead Sciences-FDA Approves Veklury (Remdesivir) for the Treatment of Non-Hospitalized..
AQ
01/21FDA Approves Veklury« (Remdesivir) for the Treatment of Non-Hospitalized Patients at Hi..
BU
01/19GILEAD SCIENCES : Announces Actions to Remove Counterfeit HIV Medications from U.S. Supply..
PU
01/18Gilead Sciences to Release Fourth Quarter & Full Year 2021 Financial Results on Tuesday..
BU
More press releases
Official Publications
Upcoming event on GILEAD SCIENCES, INC.